Results 151 to 160 of about 534 (161)

Vosoritid - Erste medikamentöse Behandlung von Kleinwuchs

Österreichische Apothekerzeitung, 2021
openaire   +1 more source

Experience with vosoritide for achondroplasia: insights from Kazakhstan

Endocrine Abstracts
Marzhan Rakhimzhanova, Assel Issabayeva, Bikhadisha Bimurat, Akmaral Nurbekova, Aigul Durmanova   +4 more
openaire   +1 more source

Vosoritid (Achondroplasie); Nutzenbewertung gemäß § 35a SGB V

2023
openaire   +1 more source

Functional Change in a Child With Achondroplasia Following 12 Months Treatment With Vosoritide—A Case Report

American Journal of Medical Genetics, Part A
Craig F. Munns, Penelope J Ireland, Theresa Carroll   +2 more
exaly  

Vosoritide Therapy in Children With Achondroplasia: Early Experience and Practical Considerations for Clinical Practice

Advances in Therapy
Janet M Legare, Tilman R Rohrer, Julie Hoover-Fong   +2 more
exaly  

Evaluation of growth velocity in patients with achondroplasia treated with vosoritide

Endocrine Abstracts
Ongen Yasemin Denkboy, Hatice Nursoy, Munever Uluba, Erdal Eren   +3 more
openaire   +1 more source

Exploring the Family Experience of Children Aged 2–4 Years Receiving Daily Vosoritide Injections: A Qualitative Study

Journal of Pediatric Nursing
Kaya Gardiner, Jenny O'Neill, Ravi Savarirayan   +2 more
exaly  

Vosoritide in achondroplasia: Hope, hurdles, and the road ahead

Journal of Pediatric Endocrinology and Diabetes
openaire   +1 more source

An Infant With Achondroplasia Worsening of the Foramen Magnum Stenosis During Early Vosoritide Treatment

Pediatrics International
Masako Aoki, Nobuhiko Nagano, Ichiro Morioka   +2 more
exaly  

6532 Safety and efficacy of vosoritide in patients with achondroplasia- a systematic review

British Society of Paediatric Endocrinology and Diabetes
Roba Al Shouli, Roba Al Shouli, Bashir Elnaem, Aqeel Farooq   +3 more
openaire   +1 more source